In Silico Evaluation of the Anti-inflammatory Potential of Rubiacordifolia (Manjistha) Phytoconstituents: Molecular Docking and ADMET Profiling
Objective: To investigate the anti-inflammatory potential of selected phytoconstituents of Rubiacordifolia (Manjistha) using molecular docking and computational pharmacokinetic profiling. Methods: A hydroalcoholic extract of R. cordifolia roots was prepared by Soxhlet extraction and the percentage yield was determined. Four major phytoconstituents, namely purpurin, rubiadin, alizarin and mollugin, were selected through literature survey and database screening, and their structures were retrieved from PubChem. Molecular docking was performed with AutoDock Vina against inflammatory target proteins (cyclooxygenase-2, COX-2; tumor necrosis factor-alpha, TNF-α; and nuclear factor-kappa B, NF-κB). Ligand–protein interactions were visualised in PyMOL. Drug-likeness and pharmacokinetic properties were predicted with SwissADME and assessed against Lipinski's Rule of Five. Results: The hydroalcoholic extract gave a yield of 13.7 ± 0.3% w/w. Purpurin showed the highest binding affinity towards COX-2 (−8.6 ± 0.3 kcal/mol) and formed four hydrogen bonds with ARG120, TYR355 and SER530. Mollugin (−8.1 ± 0.5 kcal/mol), rubiadin (−7.9 ± 0.4 kcal/mol) and alizarin (−7.4 ± 0.2 kcal/mol) also bound within the active site. All four compounds satisfied Lipinski's Rule of Five with no violations, and purpurin, rubiadin and mollugin were predicted to have high gastrointestinal absorption. Conclusion: Purpurin and mollugin emerged as the most promising COX-2-interacting constituents of R. cordifolia, with favourable drug-like properties. These findings provide computational support for the traditional use of Manjistha in inflammatory conditions and justify in vitro and in vivo validation.
Authors
- Sachin Jain (ORCID: https://orcid.org/0000-0003-1508-4895)
Publication Details
- Journal
- TMP Universal Journal of Advances in Pharmaceutical sciences
- Published
- 2026-11-19
- DOI
- https://doi.org/10.69557/823e7r73
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00